Literature DB >> 7496290

Hepatology.

A N McNair1, C J Tibbs, R Williams.   

Abstract

Mesh：

Year:  1995        PMID： 7496290      PMCID： PMC2551251          DOI： 10.1136/bmj.311.7016.1351

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  41 in total

1.  A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

Authors:  S Brillanti; J Garson; M Foli; K Whitby; R Deaville; C Masci; M Miglioli; L Barbara
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

2.  The Hepatix extracorporeal liver assist device: initial clinical experience.

Authors:  N L Sussman; G T Gislason; C A Conlin; J H Kelly
Journal:  Artif Organs       Date:  1994-05       Impact factor: 3.094

3.  Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Authors:  H C Whittle; N Maine; J Pilkington; M Mendy; M Fortuin; J Bunn; L Allison; C Howard; A Hall
Journal:  Lancet       Date:  1995-04-29       Impact factor: 79.321

4.  Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis.

Authors:  Y Noda; R D Hughes; R Williams
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

5.  Auxiliary liver transplantation for fulminant and subfulminant hepatic failure.

Authors:  K Boudjema; D Cherqui; D Jaeck; M P Chenard-Neu; A Steib; G Freis; F Becmeur; B Brunot; U Simeoni; J P Bellocq
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

6.  Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B.

Authors:  K Hamasaki; K Nakata; Y Nagayama; A Ohtsuru; M Daikoku; K Taniguchi; T Tsutsumi; Y Sato; Y Kato; S Nagataki
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

7.  Epidemiology and prevention of hepatitis A in travelers.

Authors:  R Steffen; M A Kane; C N Shapiro; N Billo; K J Schoellhorn; P van Damme
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

8.  Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha.

Authors:  L Chemello; L Cavalletto; F Noventa; P Bonetti; C Casarin; E Bernardinello; P Pontisso; C Donada; P Casarin; F Belussi
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

9.  Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

Authors: 
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

10.  A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245
View more
  1 in total

Review 1.  Liver cirrhosis.

Authors:  E J Williams; J P Iredale
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.